Pain levels may affect patient satisfaction, study says | Pain studies focus on drugs that do not cause euphoria | More data on Lpath's pain treatment sought by FDA
 
Advertisement

March 18, 2015
News for the pain professional
SIGN UP|FORWARD|ARCHIVE|ADVERTISE

Pain Research News
Pain levels may affect patient satisfaction, study says
A study in the journal Pain Practice found pain management was linked with patient satisfaction. "Optimal pain management, with emphasis on patient participation in decision-making, should be encouraged in an effort to improve the quality of care in hospitals," the authors wrote. PhysiciansBriefing.com (3/13)
Share: LinkedInTwitterFacebookGoogle+Email
Pain studies focus on drugs that do not cause euphoria
Small biotech firms and large pharmaceutical companies are working to develop pain medicines that work in different ways than opioid-based drugs. Some research is focused on limiting targets to specific opioid receptors, while other approaches avoid opioid receptors completely. Yale University neurology professor Stephen Waxman calls the search a "Holy Grail of pain research." The Wall Street Journal (tiered subscription model) (3/17)
Share: LinkedInTwitterFacebookGoogle+Email
Get Creative: 10 Ways to Think Outside the Box
No matter your business, smart solutions come from out-of-the-box thinking. We all know creativity is king, but are you doing all you can to inspire and encourage creativity in your staff? Read the article and learn 10 ways to inspire creativity at your office.
Advertisement

Treatment NewsAdvertisement
More data on Lpath's pain treatment sought by FDA
The FDA has asked Lpath to submit additional data related to its investigational new drug application for experimental antibody drug lpathomab. The antibody targets lysophosphatidic acid, which research indicates has a significant part in neuropathic and nerve-injury pain. The firm is working on a response to the agency's request. Pharmaceutical Business Review Online (3/12)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
How to Achieve IT Agility: A Survival Guide for IT Decision Makers
When business teams add new apps and services to already-strained networks, IT departments are accountable for making everything work. Is your team ready for this challenge? Read this eGuide to learn how IT teams are automating their networks, why they're utilizing Ethernet fabrics and SDN, and what success looks like as they regain network control and business relevance.
Advertisement

Policy & Trends
GAO traces some drug shortages to DEA policies
The Drug Enforcement Agency's management of production limits on some controlled substances has been a contributing factor behind shortages of some medications, a Government Accountability Office investigation found. The Wall Street Journal (tiered subscription model)/Pharmalot blog (3/11)
Share: LinkedInTwitterFacebookGoogle+Email
Push to expedite drug classification clears House
The House has passed a measure that set a 90-day timeframe for the Drug Enforcement Administration to classify new drugs. Under existing law, there is no deadline. The new measure was designed to help get potentially lifesaving treatments to patients more quickly. The Hill/Floor Action Blog (3/16)
Share: LinkedInTwitterFacebookGoogle+Email
Study: Abuse-deterrent formulation of OxyContin changed abuse patterns
A 2010 reformulation of OxyContin aimed to deter abuse shifted the patterns of abuse but didn't end it, according to a study in JAMA Psychiatry. Almost half of continuing abusers of OxyContin switched from injecting or inhaling to swallowing the drug, data showed. Two-thirds of those who switched drugs after the reformulation chose heroin, while only 3% of users totally stopped using opioids. NEJM Journal Watch (3/12)
Share: LinkedInTwitterFacebookGoogle+Email
Advertisement
 
Business Tips and Advice
Sponsored Links from American Express OPEN on openforum.com
Click here to learn more about Featured Content
APS News
Tomorrow: Data Blitz submission deadline
It's not too late to submit your research for this year's Clinical and Basic Science Data Blitz. The 2015 data blitz will include selected presentations of new and innovative research in a rapid format. Presenters will have five minutes to present their data, followed by five minutes of a question-and-answer session. The blitz will be moderated by Todd Vanderah, Ph.D., Michael Jankowski, Ph.D., Benedict Kolber, Ph.D., Marie Hoeger Bement, Ph.D., MPT, and 2014 Data Blitz session winner, Peter Grace, Ph.D. The event will be held on Wednesday, May 13, in Palm Springs, Calif., as part of the 2015 Annual Scientific Meeting. The application deadline is Thursday. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
Workshop: Managing Postoperative Pain
Discover the latest in multidisciplinary pain research and clinical care at this year's Annual Scientific Meeting in Palm Springs, Calif., from May 13 to 16. Attend a variety of sessions that focus on emerging research across disciplines, such as a workshop. APS workshops provide participants with more in-depth discussions on timely pain-related topics. "Clinical Application of American Pain Society's Guidelines for Managing Postoperative Pain" will discuss management strategies for reducing and managing postoperative pain in adults and children. This workshop will incorporate recommendations and implementation set by evidence-based clinical practice guidelines published by APS. This workshop will be held on Friday, May 15, and offers three continuing-education credits and two hours of pharmacology hours. Register by Monday, April 13, and get $100 off of registration. Register now.
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
The vitality of a new movement in art must be gauged by the fury it arouses."
-- Logan Pearsall Smith,
essayist
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about APS ->Membership | Annual Meeting | Education | Funding Opportunities | About Us
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tom Parks
Advertising:  Wynn Hansen
  P: 202.470.1149
 
 

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information